(AOF) – For its third quarter, Lacroix generated a turnover of 179.7 million euros, an increase of 0.9% compared to the same period of 2022. The specialist in equipment and technologies connected was able to count on the dynamism of the City (+16.4%) and Environment (+10.2%) activities, while the Electronics activity fell by 3.2%. Cumulatively over the first 9 months of the year, the group’s turnover increased by 9.9% (+9.6% at constant scope and exchange rate), reaching 567.4 million euros.
In terms of prospects, Lacroix remains confident in achieving a turnover in excess of 750 million euros in 2023 on a constant scope, an increase of at least 6%.
In terms of profitability, EBITDA is now expected to be around 45 million euros compared to an initial objective of more than 50 million euros, the difference coming entirely from the electronic activity in North America impacted by the concomitance of several transient factors.
This objective, adjusted taking into account recent changes in business conditions, remains higher than the EBITDA achieved for the 2022 financial year (44.3 million euros).
The company will publish its annual results on February 8, 2024 after market trading.
AOF – LEARN MORE
Sector sheet – Electronics
Innovations are developing in connected health
At the last CES, innovations in health made significant progress. Thanks to the operation of Artificial Intelligence, numerous objects measuring each person’s constants and communicating in all rooms have been disclosed. Sensors can analyze urine, monitor nutrient or hormone levels. Other objects can measure blood pressure, heart rate and other indicators by analyzing the face from a selfie. Products in the prevention niche are very promising, as are certain start-ups, such as the French company Withings. After its Body Scan, a connected health station for the home, the company is preparing to market the first home urine analysis laboratory. It thus faces American giants like Apple in the prevention market.